The BioCentury Europe index gained 4% in 1Q14, while the BioCentury London index declined by 2%. Fifteen of 19 continental European biotechs in the market cap-weighted BC Europe index advanced last quarter, led by a 266% increase in the value of Pharming Group N.V. (Euronext:PHARM) to €173.8